Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
DK.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.11.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.63NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FM.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GA.4.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GK.1.10.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EG.10NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GN.1.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.13.3.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GW.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.424NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.198NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.366NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.441NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.416NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.63NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.263NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.135NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-19375South Korea
FK.1.4.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.13NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
DR.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.516NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.354NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.162NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.426NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.402NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.424NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.61NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.264NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.581NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.330NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.205NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.177NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.301NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.308NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.210NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.325NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.590NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.116NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.496NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.438.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.49 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.507NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.178NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.273NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.211NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.474NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.14NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.297NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AH.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used